UC Law San Francisco

The provided news articles focus on the US Food and Drug Administration's (FDA) decision to decline reviewing Moderna's application for a new flu vaccine. The articles do not mention UC Law San Francisco. The FDA's unexpected refusal to consider the application, despite previously supporting the project, is the central issue. Experts suggest this decision, potentially influenced by the previous administration, could negatively impact the development and approval of new and updated vaccines in the US. The articles highlight concerns about the FDA's processes and the potential implications for public health and vaccine innovation. The situation is relevant due to the ongoing need for effective flu vaccines and the potential chilling effect on future vaccine development efforts.